Atlas Trials

Trust Bio-sonics, Inc.

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Trust Bio-sonics, Inc.

RecordFirmDate
A Prospective, Multicenter, Phase III Clinical Evaluation of the Safety and Efficacy of NH002 as a Contrast Agent Administrated Via Intravenous Bolus Injection and Infusion for Subjects Undergoing Cardiac Echocardiography (NCT07740421)Trust Bio-sonics, Inc.2026-07-01
Safety and Efficacy Evaluation of NH002 as a Contrast Agent in Subjects Undergoing Cardiac Echocardiography (NCT06815627)Trust Bio-sonics, Inc.2025-03-18
A Dose Ascending Study to Evaluate the Safety of NH002 as a Contrast Agent in Cardiac Echocardiography (NCT04185246)Trust Bio-sonics, Inc.2019-11-04

Track Trust Bio-sonics, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.